14-day Premium Trial Subscription Try For FreeTry Free
$90.87
-0.640 (-0.699%)
At Close: Apr 16, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $83.66 $93.35 Tuesday, 16th Apr 2024 BMRN stock ended at $90.87. This is 0.699% less than the trading day before Monday, 15th Apr 2024. During the day the stock fluctuated 1.80% from a day low at $90.16 to a day high of $91.78.
90 days $83.44 $94.51
52 weeks $76.02 $100.31

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2023-09-11 $90.20 $90.91 $89.63 $90.86 1 170 614
2023-09-08 $90.81 $91.37 $89.85 $90.19 796 334
2023-09-07 $90.72 $90.99 $89.05 $90.42 1 124 762
2023-09-06 $90.35 $91.48 $90.29 $91.00 955 409
2023-09-05 $92.48 $92.61 $90.63 $90.74 1 142 098
2023-09-01 $92.21 $93.73 $91.54 $93.03 979 121
2023-08-31 $94.42 $95.03 $91.18 $91.38 1 312 701
2023-08-30 $95.00 $95.13 $93.52 $93.81 794 239
2023-08-29 $93.30 $94.65 $92.09 $94.48 1 048 432
2023-08-28 $94.00 $94.39 $92.85 $93.68 1 343 688
2023-08-25 $93.54 $93.89 $91.98 $93.64 725 123
2023-08-24 $91.35 $93.27 $91.08 $93.14 1 088 465
2023-08-23 $91.12 $91.16 $90.04 $91.07 745 322
2023-08-22 $89.94 $90.87 $89.79 $90.53 484 920
2023-08-21 $88.89 $90.38 $88.74 $89.87 819 908
2023-08-18 $89.27 $90.14 $88.46 $89.05 1 043 348
2023-08-17 $90.00 $90.78 $89.32 $89.40 686 128
2023-08-16 $90.00 $90.73 $89.45 $90.00 649 331
2023-08-15 $90.20 $91.16 $89.72 $90.67 582 458
2023-08-14 $89.29 $90.77 $89.01 $90.29 688 058
2023-08-11 $90.57 $90.78 $88.94 $89.41 993 103
2023-08-10 $93.21 $93.32 $89.78 $90.91 1 325 079
2023-08-09 $91.29 $94.06 $91.24 $93.23 1 679 612
2023-08-08 $88.29 $90.86 $87.93 $90.62 1 394 204
2023-08-07 $88.10 $88.17 $87.25 $87.83 817 015
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Golden Star

Ticker Date Change Price
LXP Apr 05 0.790% $8.86
AKR Apr 05 4.23% $16.53
SARK Mar 28 12.46% $26.88
ARCC Mar 25 0.596% $20.12
STT Mar 19 3.18% $72.62
GGB Mar 19 4.45% $4.27
LNC Mar 18 2.61% $27.17
CAG Mar 18 5.46% $28.22
CMC Mar 14 4.83% $53.19
MASI Mar 14 4.47% $132.20
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT